Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.69M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Cellectar Biosciences, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −13 vs. Q1 2025
- Shares held
- 103.4K
- −5.10M (−98.0%) vs. Q1 2025
- Total value
- $734.0K
- −$894.3K (−54.9%) vs. Q1 2025
- New holders
- 6
- 0 more added
- Sold out
- 19
- 13 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $9.69M |
| Q1 2026 | 19 | $812.9K |
| Q4 2025 | 20 | $1.04M |
| Q3 2025 | 21 | $1.65M |
| Q2 2025 | 19 | $734.0K |
| Q1 2025 | 32 | $1.63M |
| Q4 2024 | 30 | $1.52M |
| Q3 2024 | 35 | $30.0M |
| Q2 2024 | 37 | $33.0M |
| Q1 2024 | 45 | $36.5M |
| Q4 2023 | 26 | $27.6M |
| Q3 2023 | 20 | $3.85M |
| Q2 2023 | 21 | $3.08M |
| Q1 2023 | 21 | $2.43M |
| Q4 2022 | 26 | $3.22M |
| Q3 2022 | 22 | $2.14M |
| Q2 2022 | 33 | $3.65M |
| Q1 2022 | 32 | $4.69M |
| Q4 2021 | 42 | $4.41M |
| Q3 2021 | 40 | $6.77M |
| Q2 2021 | 46 | $14.9M |
| Q1 2021 | 45 | $24.2M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Cellectar Biosciences, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 56,341 | $400.6K | 0.00% | −1,665,497−96.7% | Reduced |
| Geode Capital Management, LLC | 14,439 | $102.7K | 0.00% | −428,985−96.7% | Reduced |
| HRT Financial LP | 12,578 | $89.0K | 0.00% | −33,658−72.8% | Reduced |
| Riverview Capital Advisers, LLC | 10,500 | $74.7K | 0.02% | +10,500 | New |
| BlackRock, Inc. | 4,742 | $33.7K | 0.00% | −226,072−97.9% | Reduced |
| UBS Group AG | 3,620 | $25.7K | 0.00% | −916,732−99.6% | Reduced |
| Morgan Stanley | 510 | $3.63K | 0.00% | −14,795−96.7% | Reduced |
| Tower Research Capital LLC (TRC) | 195 | $1.39K | 0.00% | +195 | New |
| Simplex Trading, LLC | 238 | $1.00K | 0.00% | −172,891−99.9% | Reduced |
| Raymond James Financial Inc | 133 | $946 | 0.00% | +133 | New |
| Group One Trading, L.P. | 56 | $398 | 0.00% | −1,342−96.0% | Reduced |
| Advisor Group Holdings, Inc. | 22 | $155 | 0.00% | −899−97.6% | Reduced |
| SBI Securities Co., Ltd. | 11 | $78 | 0.00% | −389−97.3% | Reduced |
| Jones Financial Companies LLLP | 3 | $24 | 0.00% | +3 | New |
| US Bancorp | 3 | $21 | 0.00% | −97−97.0% | Reduced |
| Bank of America Corp | 2 | $14 | 0.00% | −345−99.4% | Reduced |
| Danske Bank A/S | 2 | $14 | 0.00% | +2 | New |
| Harbour Investments, Inc. | 1 | $7 | 0.00% | −49−98.0% | Reduced |
| Citigroup Inc | 1 | $7 | 0.00% | +1 | New |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −370,865−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −343,258−100.0% | Sold out |
| Sequoia Financial Advisors, LLC | 0 | $0 | 0.00% | −203,260−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −172,940−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −128,114−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −104,323−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −83,099−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −77,988−100.0% | Sold out |
| Rochester Wealth Strategies, LLC | 0 | $0 | 0.00% | −43,000−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −40,228−100.0% | Sold out |
| Nordwand Advisors, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −17,587−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −12,051−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,807−100.0% | Sold out |
| Commerce Bank | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,646−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| AllSquare Wealth Management LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |